ATANIS Biotech Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 4

ATANIS Biotech General Information

Description

Operator of a biotechnology company intended to simplify and improve the current standard of care for the diagnosis of allergies. The company offers a novel functional cell-based assay that simplifies the diagnosis of allergies and can predict the treatment success of therapies, enabling clients with a reliable tool for functional allergy screening.

Contact Information

Website
www.atanis-biotech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Freiburgstrasse 251
  • 3018 Bern
  • Switzerland
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Freiburgstrasse 251
  • 3018 Bern
  • Switzerland

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ATANIS Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 22-Oct-2024 Completed Generating Revenue
1. Early Stage VC 28-Mar-2023 Completed Generating Revenue
To view ATANIS Biotech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

ATANIS Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ATANIS Biotech Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Spectrum Moonshot Fund Venture Capital Minority
AllerFund Ventures Venture Capital Minority
Business Angels Angel Group Minority
iXCore Venture Capital Minority
To view ATANIS Biotech’s complete investors history, request access »

Ready to get started?

Request a free trial

ATANIS Biotech FAQs

  • When was ATANIS Biotech founded?

    ATANIS Biotech was founded in 2021.

  • Where is ATANIS Biotech headquartered?

    ATANIS Biotech is headquartered in Bern, Switzerland.

  • What is the size of ATANIS Biotech?

    ATANIS Biotech has 20 total employees.

  • What industry is ATANIS Biotech in?

    ATANIS Biotech’s primary industry is Laboratory Services (Healthcare).

  • Is ATANIS Biotech a private or public company?

    ATANIS Biotech is a Private company.

  • What is ATANIS Biotech’s current revenue?

    The current revenue for ATANIS Biotech is .

  • Who are ATANIS Biotech’s investors?

    Spectrum Moonshot Fund, AllerFund Ventures, Business Angels, and iXCore have invested in ATANIS Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »